Lexaria Bioscience
LEXX
LEXX
16 hedge funds and large institutions have $1.67M invested in Lexaria Bioscience in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
1% less capital invested
Capital invested by funds: $1.68M → $1.67M (-$8.44K)
Holders
16
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$63.7K | |
| 2 | +$6.61K | |
| 3 | +$3.33K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$406 |
| 5 |
Wells Fargo
San Francisco,
California
|
+$2 |
Top Sellers
| 1 | -$32K | |
| 2 | -$15.2K | |
| 3 | -$1.97K | |
| 4 |
Renaissance Technologies
New York
|
-$974 |
| 5 |
CC
Centiva Capital
New York
|
-$490 |